Company

Akari Therapeutics Plc

AKTX · CIK 0001541157

SEC FORM 4

$62,499.60

Acquisition (code A) of 6,430 shares at $9.72 per share.

Reporting Person Gaslightwala Abizer · Officer Title CEO · Transaction Code A

Traded Sep 29, 2026 · Disclosed Oct 1, 2026

Source: SEC Form 4 · 0001493152-26-045366 · filed 2026-10-01 · View filing →

SEC FORM 4

$12,994.56

Acquisition (code A) of 1,728 shares at $7.52 per share.

Reporting Person Farag Kameel D. · Officer Title Interim CFO · Transaction Code A

Traded Aug 17, 2026 · Disclosed Aug 19, 2026

Source: SEC Form 4 · 0001493152-26-039246 · filed 2026-08-19 · View filing →